Ani Pharmaceuticals (ANIP) Long-Term Investments (2010 - 2013)

Ani Pharmaceuticals has disclosed Long-Term Investments across 4 years of filings, most recently posting $3.4 million for Q1 2013.

• Long-Term Investments for Q1 2013 came in at $3.4 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2013 was $3.4 million (changed 0.0% YoY), and the FY2012 annual result was $3.4 million, changed 0.23% from the prior year.
• Long-Term Investments came in at $3.4 million for Q1 2013 at Ani Pharmaceuticals, roughly flat from $3.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $3.4 million in Q1 2012 to a low of $3.4 million in Q4 2010.
• The 4-year median for Long-Term Investments is $3.4 million (2012), against an average of $3.4 million.
• Across the five-year window, Long-Term Investments changed 0.0% in 2011 and gained 0.23% in 2012, its largest moves.
• Ani Pharmaceuticals' Long-Term Investments stood at $3.4 million in 2010, then changed by 0.0% to $3.4 million in 2011, then increased by 0.23% to $3.4 million in 2012, then changed by 0.0% to $3.4 million in 2013.
• The last three Long-Term Investments figures came in at $3.4 million (Q1 2013), $3.4 million (Q4 2012), and $3.4 million (Q3 2012), per Business Quant data.